Oxytocin with therapy for challenging behaviors in some children
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial studies whether oxytocin, given alongside structured psycho-educational support, can be safe and feasible in helping children with autism and moderate-to-severe intellectual disability who have challenging behaviors. It focuses on whether the added treatment can work without unacceptable side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has autism spectrum disorder and moderate to severe intellectual disability
- Your child has significant challenging behaviors, assessed by specialist checklists
- Your family is already receiving structured, coordinated therapy plans and education support
- If your child takes certain psychiatric medicines, doses must be stable for the past 3 months
- Both parents (if applicable) can understand French and complete the study steps and questionnaires
- Parents must agree and sign the consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a nasal spray containing oxytocin can help youth with autism spectrum disorder. It focuses on participants who are healthy enough for the spray and able to follow study instructions, and it avoids people with certain nasal problems or allergies.
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
This study tests whether a drug called MDMA changes oxytocin levels (a hormone related to social bonding) differently in autistic adults compared to non-autistic adults. Researchers want to understand if MDMA might help with social challenges some autistic people experience.
This study looks at different treatments (medication, behavioral therapy, or both) for children with autism and intellectual disability who have challenging behaviors like aggression or self-injury. It aims to understand what works best for each child.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This trial tests a new brain stimulation therapy (called NeuroCytotron) to see if it helps children with autism who have some verbal communication. The goal is to help the brain form new connections and improve symptoms.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.